Related Experiment Video

Updated: May 15, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Rational design of the survivin/CDK4 complex by combining protein-protein docking and molecular dynamics simulations

Jana Selent1, Agnieszka A Kaczor, Ramon Guixà-González

  • 1Research Programme on Biomedical Informatics (GRIB), IMIM/Universitat Pompeu Fabra, Dr. Aiguader 88, 08003 Barcelona, Spain.

Journal of Molecular Modeling
|December 25, 2012
PubMed

Insights

Researchers modeled the survivin/CDK4 complex, crucial for cell division and cancer. This structural model aids in designing novel anticancer drugs targeting protein interactions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Survivin, an inhibitor of apoptosis protein (IAP), plays roles in apoptosis and cell cycle regulation.
  • Survivin is proposed to form a complex with cyclin-dependent kinase 4 (CDK4), facilitating nuclear transport for cell division.
  • Targeting protein-protein interactions involving survivin offers a strategy for developing anticancer compounds.

Purpose of the Study:

  • To propose a rational structural model of the survivin/CDK4 complex.
  • To provide a basis for structure-based drug design targeting the survivin/CDK4 interface.
  • To elucidate the molecular mechanisms underlying survivin's role in cell cycle regulation.

Main Methods:

  • Protein-protein docking simulations.
  • Fractal-based shape complementarity analysis.
  • Electrostatics studies and molecular dynamics simulations.

Main Results:

  • A structural model for the survivin/CDK4 complex was developed, consistent with experimental data.
  • The model highlights the involvement of survivin's alpha-helical domain in complex formation.
  • The binding mode resembles that observed in the survivin/borealin X-ray structure.

Conclusions:

  • The proposed survivin/CDK4 complex model provides insights into its function in cell division.
  • This model serves as a valuable tool for designing novel inhibitors targeting the survivin/CDK4 interaction.
  • Disrupting survivin-mediated complexes presents a promising avenue for cancer therapy.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...